AAAAAA
Results: 1-25/41
Authors:
Torchilin, VP
Iakoubov, LZ
Estrov, Z
Citation: Vp. Torchilin et al., Antinuclear autoantibodies as potential antineoplastic agents, TRENDS IMMU, 22(8), 2001, pp. 424-427
Authors:
Ferrajoli, A
Manshouri, T
Estrov, Z
Keating, MJ
O'Brien, S
Lerner, S
Beran, M
Kantarjian, HM
Freireich, EJ
Albitar, M
Citation: A. Ferrajoli et al., High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia, CLIN CANC R, 7(4), 2001, pp. 795-799
Authors:
Faderl, S
Estrov, Z
Citation: S. Faderl et Z. Estrov, The clinical significance of caspase regulation in acute leukemia, LEUK LYMPH, 40(5-6), 2001, pp. 471-481
Authors:
Verstovsek, S
Kantarjian, H
Estey, E
Aguayo, A
Giles, FJ
Manshouri, T
Koller, C
Estrov, Z
Freireich, E
Keating, M
Albitar, M
Citation: S. Verstovsek et al., Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome, LEUKEMIA, 15(8), 2001, pp. 1165-1170
Authors:
Sarriera, JE
Albitar, M
Estrov, Z
Gidel, C
Aboul-Nasr, R
Manshouri, T
Kornblau, S
Chang, KS
Kantarjian, H
Estey, E
Citation: Je. Sarriera et al., Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing, LEUKEMIA, 15(1), 2001, pp. 57-61
Authors:
Milella, M
Kornblau, SM
Estrov, Z
Carter, BZ
Lapillonne, H
Harris, D
Konopleva, M
Zhao, SR
Estey, E
Andreeff, M
Citation: M. Milella et al., Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia., J CLIN INV, 108(6), 2001, pp. 851-859
Authors:
Wang, Y
Liu, JX
Wu, Y
Luo, WP
Lin, SH
Lin, H
Hawk, N
Sun, T
Guo, JQ
Estrov, Z
Talpaz, M
Champlin, R
Arlinghaus, RB
Citation: Y. Wang et al., Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death, CANCER RES, 61(1), 2001, pp. 138-144
Authors:
Ravandi, F
Kantarjian, HM
Talpaz, M
O'Brien, S
Faderl, S
Giles, FJ
Thomas, D
Cortes, J
Andreeff, M
Estrov, Z
Rios, MB
Albitar, M
Citation: F. Ravandi et al., Expression of apoptosis proteins in chronic myelogenous leukemia - Associations and significance, CANCER, 91(11), 2001, pp. 1964-1972
Authors:
Kardinal, C
Konkol, B
Lin, H
Eulitz, M
Schmidt, EK
Estrov, Z
Talpaz, M
Arlinghaus, RB
Feller, SM
Citation: C. Kardinal et al., Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-SoS complexes, BLOOD, 98(6), 2001, pp. 1773-1781
Authors:
Faderl, S
Estrov, Z
Citation: S. Faderl et Z. Estrov, Hematopoietic growth factors and cytokines, J CLIN LIG, 23(3), 2000, pp. 169-180
Authors:
Kornblau, SM
Vu, HT
Ruvolo, P
Estrov, Z
O'Brien, S
Cortes, J
Kantarjian, H
Andreeff, M
May, WS
Citation: Sm. Kornblau et al., BAX and PKC alpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia, CLIN CANC R, 6(4), 2000, pp. 1401-1409
Authors:
Ueno, NT
Bartholomeusz, C
Herrmann, JL
Estrov, Z
Shao, RP
Andreeff, M
Price, J
Paul, RW
Anklesaria, P
Yu, DH
Hung, MC
Citation: Nt. Ueno et al., E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway, CLIN CANC R, 6(1), 2000, pp. 250-259
Authors:
Faderl, S
Kantarjian, HM
Thomas, DA
Cortes, J
Giles, F
Pierce, S
Albitar, M
Estrov, Z
Citation: S. Faderl et al., Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia, LEUK LYMPH, 36(3-4), 2000, pp. 263-273
Authors:
Faderl, S
Kantarjian, HM
Talpaz, M
Estrov, Z
Citation: S. Faderl et al., Clinical significance of minimal residual disease in leukemia (Review), INT J ONCOL, 17(6), 2000, pp. 1277-1287
Authors:
Kardinal, C
Konkol, B
Schulz, A
Posern, G
Lin, H
Adermann, K
Eulitz, M
Estrov, Z
Talpaz, M
Arlinghaus, RB
Feller, SM
Citation: C. Kardinal et al., Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients, FASEB J, 14(11), 2000, pp. 1529-1538
Authors:
Stock, W
Estrov, Z
Citation: W. Stock et Z. Estrov, Studies of minimal residual disease in acute lymphocytic leukemia, HEMAT ONCOL, 14(6), 2000, pp. 1289
Authors:
Mavligit, GM
Estrov, Z
Citation: Gm. Mavligit et Z. Estrov, CA 125: A clinically useful tumor marker in the management of colorectal carcinoma metastatic to the liver in patients with normal carcinoembryonic antigen, AM J CL ONC, 23(2), 2000, pp. 213-215
Authors:
Faderl, S
Kantarjian, HM
Estey, E
Manshouri, T
Chan, CY
Elsaied, AR
Kornblau, SM
Cortes, J
Thomas, DA
Pierce, S
Keating, MJ
Estrov, Z
Albitar, M
Citation: S. Faderl et al., The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia, CANCER, 89(9), 2000, pp. 1976-1982
Authors:
Aguayo, A
Kantarjian, H
Manshouri, T
Gidel, C
Estey, E
Thomas, D
Koller, C
Estrov, Z
O'Brien, S
Keating, M
Freireich, E
Albitar, M
Citation: A. Aguayo et al., Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes, BLOOD, 96(6), 2000, pp. 2240-2245
Authors:
Konopleva, M
Tari, AM
Estrov, Z
Harris, D
Xie, Z
Zhao, SR
Lopez-Berestein, G
Andreeff, M
Citation: M. Konopleva et al., Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins, BLOOD, 95(12), 2000, pp. 3929-3938
Authors:
Faderl, S
Estrov, Z
Kantarjian, HM
Thomas, D
Cortes, J
Manshouri, T
Chan, CC
Hays, KJ
Pierce, S
Albitar, M
Citation: S. Faderl et al., The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia, CYTOK CELL, 5(3), 1999, pp. 159-163
Authors:
Kornblau, SM
Thall, PF
Estrov, Z
Walterscheid, M
Patel, S
Theriault, A
Keating, MJ
Kantarjian, H
Estey, E
Andreeff, M
Citation: Sm. Kornblau et al., The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics, CLIN CANC R, 5(7), 1999, pp. 1758-1766
Authors:
Faderl, S
Kantarjian, HM
Manshouri, T
Chan, CY
Pierce, S
Hays, KJ
Cortes, J
Thomas, D
Estrov, Z
Albitar, M
Citation: S. Faderl et al., The prognostic significance of p16(INK4a)/p14(ARF) and p15(INK4b) deletions in adult acute lymphoblastic leukemia, CLIN CANC R, 5(7), 1999, pp. 1855-1861
Authors:
Ravandi, F
Estrov, Z
Kurzrock, R
Breitmeyer, JB
Maschek, BJ
Talpaz, M
Citation: F. Ravandi et al., A phase I study of recombinant interferon-beta in patients with advanced malignant disease, CLIN CANC R, 5(12), 1999, pp. 3990-3998
Authors:
Faderl, S
Thall, PF
Kantarjian, HM
Talpaz, M
Harris, D
Van, Q
Beran, M
Kornblau, SM
Pierce, S
Estrov, Z
Citation: S. Faderl et al., Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia, CLIN CANC R, 5(12), 1999, pp. 4041-4047